These findings imply that HBeAg might influence the anti-replication roles associated with INTS10 and IRF3 in individuals affected by hepatitis B. Therefore, our results could enhance the clinical approach to managing HBV infections. Here, IRF3 is linked to hepatitis B virus infection.